PORTEC 2: Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk Last updated on Apr 21, 2024 Previous RUBY - Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer Next DESKTOP Trial - Secondary Debulking Surgery
